Executive Director, Contracts & Pricing Strategy – Oncology & Ophthalmology

Join Amgen’s Mission of Serving Patients

At Amgen, if you feel like you are a part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do. Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year.

As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives. Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team.

Join us and transform the lives of patients while transforming your career.

Let’s do this. Let’s change the world. In this vital role, the Executive Director, Contracts & Pricing Strategy – Oncology & Ophthalmology is a senior leader within the U.S. Value & Access (USV&A) organization and a core member of the Contracts & Pricing Strategy and Execution Leadership Team. This individual is accountable for setting and executing U.S. payer and provider contracting, pricing, and access strategies across Amgen’s Oncology and Ophthalmology portfolios to ensure optimal patient access while achieving enterprise net price and gross-to-net (GTN) objectives.

The Executive Director will lead, recruit, and develop a high-performing team responsible for translating portfolio strategy into brand-specific execution. This role requires close collaboration with Brand Leads/General Managers to align short- and long-term pricing and contracting objectives, including making disciplined strategic tradeoffs between coverage, access, and financial performance. To ensure strategic and executional alignment, the Executive Director will serve as a key integrator across Brand, Finance, Commercial Data & Analytics (CD&A), Medical, Patient Access, Value Marketing, Global Health Economics (GHE), Trade, Policy, Legal, and Compliance.

The role will also support the Market Access and National Account teams in major payer, provider, GPO, and health system engagements.

• Own and execute U.S. payer and provider contracting and pricing strategy across the Oncology and Ophthalmology portfolios, ensuring consistency where appropriate while accounting for therapeutic, site-of-care, and channel-specific dynamics
• Establish portfolio-level contracting guardrails, decision frameworks, and governance to guide brand-level execution and tradeoff decisions
• Serve as a member of the Oncology Leadership Core Team, contributing to cross-portfolio strategy and execution across the business unit

• In partnership with Brand, Finance, and CD&A teams, provide forecasted coverage, pricing, and GTN assumptions into:
  • Quarterly Latest Estimate Discount Rate (LEDR)
  • Quarterly Business Reviews (QBRs)
  • Long-Range Scenario (LRS) planning including clear messaging for executive leadership.
• Lead proactive support for bi-annual strategic planning and quarterly performance reviews
• Manage budgets for all value-related work streams across the Oncology and Ophthalmology portfolios

• Coach and empower teams to develop comprehensive coverage and net price plans for each product, including:
  • Core pricing and access assumptions
  • Payer and provider contract platforms
  • Pull-through and execution resources for Market Access teams
  • Collaborate with Patient Access and Brand teams to maintain and evolve patient support programs in real time to address access barriers and pull-through opportunities
  • Partner with Value Marketing to develop therapeutic-area-specific value strategies, messaging, tools, and evidence generation plans aligned with brand strategy
  • Collaborate with Training, Brand, and Sales to develop Market Access Team and field meeting content, semester plans of action, and coverage goals.